These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21371849)

  • 1. Injection drug users' experience with and attitudes toward methadone clinics in Denver, CO.
    Al-Tayyib AA; Koester S
    J Subst Abuse Treat; 2011 Jul; 41(1):30-6. PubMed ID: 21371849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring stakeholder perceptions of facilitators and barriers to accessing methadone maintenance clinics in Yunnan Province, China.
    Philbin MM; Zhang F
    AIDS Care; 2010 May; 22(5):623-9. PubMed ID: 20229375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Avants SK; Margolin A; Usubiaga MH; Doebrick C
    J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misconceptions toward methadone maintenance treatment (MMT) and associated factors among new MMT users in Guangzhou, China.
    Xu H; Gu J; Lau JT; Zhong Y; Fan L; Zhao Y; Hao C; He W; Ling W
    Addict Behav; 2012 May; 37(5):657-62. PubMed ID: 22353775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
    Williams AB; McNelly EA; Williams AE; D'Aquila RT
    AIDS Care; 1992; 4(1):35-41. PubMed ID: 1314099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Treloar C; Newland J; Rance J; Hopwood M
    J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incarcerated intravenous heroin users: predictors of post-release utilization of methadone maintenance treatment.
    Lin HC; Wang PW; Yang YH; Tsai JJ; Yen CF
    J Addict Dis; 2016; 35(2):109-18. PubMed ID: 26670167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is low threshold methadone maintenance treatment?
    Strike C; Millson M; Hopkins S; Smith C
    Int J Drug Policy; 2013 Nov; 24(6):e51-6. PubMed ID: 23743178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of heroin use despite methadone treatment: poor coping self-efficacy predicts continued heroin use.
    Senbanjo R; Wolff K; Marshall EJ; Strang J
    Drug Alcohol Rev; 2009 Nov; 28(6):608-15. PubMed ID: 19930013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for treatment retention in methadone programs in Indonesia.
    Sarasvita R; Tonkin A; Utomo B; Ali R
    J Subst Abuse Treat; 2012 Apr; 42(3):239-46. PubMed ID: 21943812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection drug users' perceptions of drug treatment services and attitudes toward substitution therapy: a qualitative study in three Russian cities.
    Bobrova N; Alcorn R; Rhodes T; Rughnikov I; Neifeld E; Power R
    J Subst Abuse Treat; 2007 Dec; 33(4):373-8. PubMed ID: 17499960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors influencing the rate on retention to methadone maintenance treatment program among heroin addicts in Guizhou, China].
    Liang T; Liu EW; Zhong H; Wang B; Shen LM; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):131-5. PubMed ID: 19565871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug use and HIV/AIDS in China.
    Liu Z; Lian Z; Zhao C
    Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.